Clin2Atlas
AtlasInfectionsNeglected tropical diseases and malaria

Dengue

4Curable or preventable in mostAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

Milestones

dot size = significance
199020002010202020252018 — Chimeric yellow fever dengue virus, live attenuated approved (FDA)2022 — Dengue virus, live attenuated approved (FDA)
2018: Drug approval — Chimeric yellow fever dengue virus, live attenuated approved (FDA). 2022: Drug approval — Dengue virus, live attenuated approved (FDA)

What's being tested now

2018: 1 trials started2019: 1 trials started2021: 1 trials started2022: 2 trials started2023: 2 trials started2024: 5 trials started2025: 16 trials started2026: 14 trials started2020202616

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

See all 41 active Dengue trials on Clin2 →

Related

MalariaChagas diseaseAfrican trypanosomiasisSchistosomiasisCysticercosisCystic echinococcosisLymphatic filariasisOnchocerciasisTrachomaYellow feverRabiesFood-borne trematodiases

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.